455 related articles for article (PubMed ID: 23955585)
41. Multicenter phase II study of modified FOLFOX6 as neoadjuvant chemotherapy for patients with unresectable liver-only metastases from colorectal cancer in Japan: ROOF study.
Takahashi T; Shibata Y; Tojima Y; Tsuboi K; Sakamoto E; Kunieda K; Matsuoka H; Suzumura K; Sato M; Naganuma T; Sakamoto J; Morita S; Kondo K
Int J Clin Oncol; 2013 Apr; 18(2):335-42. PubMed ID: 22383023
[TBL] [Abstract][Full Text] [Related]
42. mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808): a multicenter phase II trial comprising the final analysis for survival.
Yasuno M; Uetake H; Ishiguro M; Mizunuma N; Komori T; Miyata G; Shiomi A; Kagimura T; Sugihara K
Int J Clin Oncol; 2019 May; 24(5):516-525. PubMed ID: 30612267
[TBL] [Abstract][Full Text] [Related]
43. MINOAS: A Single-arm Translational Phase II Trial of FOLFIRI Plus Aflibercept as First-line Therapy in Unresectable, Metastatic Colorectal Cancer.
Matikas A; Souglakos J; Katsaounis P; Kotsakis A; Kouroupakis P; Pantazopoulos N; Kentepozidis N; Nikolaidi A; Messaritakis I; Tzovara I; Hatzidaki D; Prinarakis E; Georgoulias V
Target Oncol; 2019 Jun; 14(3):285-293. PubMed ID: 31203498
[TBL] [Abstract][Full Text] [Related]
44. Phase II Trial of S-1 and Oxaliplatin Plus Cetuximab for Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases (KSCC1002).
Oki E; Emi Y; Miyamoto Y; Kabashima A; Higashi H; Ogata Y; Ikebe M; Saeki H; Tokunaga S; Shirabe K; Beppu T; Uchida S; Takatsuki M; Sakoda M; Eguchi S; Akagi Y; Kakeji Y; Baba H; Natsugoe S; Maehara Y;
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1067-74. PubMed ID: 26334293
[TBL] [Abstract][Full Text] [Related]
45. Advances in neoadjuvant therapy for colorectal cancer with liver metastases.
Pozzo C; Barone C; Kemeny NE
Cancer Treat Rev; 2008 Jun; 34(4):293-301. PubMed ID: 18291590
[TBL] [Abstract][Full Text] [Related]
46. What is a safe future liver remnant size in patients undergoing major hepatectomy for colorectal liver metastases and treated by intensive preoperative chemotherapy?
Narita M; Oussoultzoglou E; Fuchshuber P; Pessaux P; Chenard MP; Rosso E; Nobili C; Jaeck D; Bachellier P
Ann Surg Oncol; 2012 Aug; 19(8):2526-38. PubMed ID: 22395987
[TBL] [Abstract][Full Text] [Related]
47. Up-front systemic chemotherapy is a feasible option compared to primary tumor resection followed by chemotherapy for colorectal cancer with unresectable synchronous metastases.
Niitsu H; Hinoi T; Shimomura M; Egi H; Hattori M; Ishizaki Y; Adachi T; Saito Y; Miguchi M; Sawada H; Kochi M; Mukai S; Ohdan H
World J Surg Oncol; 2015 Apr; 13():162. PubMed ID: 25908502
[TBL] [Abstract][Full Text] [Related]
48. Liver transplantation in a patient with unresectable colorectal liver metastases -- a case report.
Hrehoreţ D; Alexandrescu S; Braşoveanu V; Grigorie R; Zielinski C; Popescu I
Chirurgia (Bucur); 2013; 108(5):719-24. PubMed ID: 24157119
[TBL] [Abstract][Full Text] [Related]
49. Preoperative Chemotherapy Can Change the Surgical Procedure for Hepatectomy in Patients with Liver Metastasis of Colorectal Cancer.
Sasaki Y; Osada S; Matsui S; Imai H; Tanahashi T; Tanaka Y; Matsuhashi N; Okumura N; Yamaguchi K; Yoshida K
Anticancer Res; 2015 Oct; 35(10):5485-9. PubMed ID: 26408713
[TBL] [Abstract][Full Text] [Related]
50. Intra-arterial yttrium-90 radioembolization combined with systemic chemotherapy is a promising method for downstaging unresectable huge intrahepatic cholangiocarcinoma to surgical treatment.
Rayar M; Sulpice L; Edeline J; Garin E; Levi Sandri GB; Meunier B; Boucher E; Boudjema K
Ann Surg Oncol; 2015 Sep; 22(9):3102-8. PubMed ID: 25623598
[TBL] [Abstract][Full Text] [Related]
51. Optimal indication criteria for neoadjuvant chemotherapy in patients with resectable colorectal liver metastases.
Ichida H; Mise Y; Ito H; Ishizawa T; Inoue Y; Takahashi Y; Shinozaki E; Yamaguchi K; Saiura A
World J Surg Oncol; 2019 Jun; 17(1):100. PubMed ID: 31196104
[TBL] [Abstract][Full Text] [Related]
52. Is Liver Transplantation an Option in Colorectal Cancer Patients with Nonresectable Liver Metastases and Progression on All Lines of Standard Chemotherapy?
Dueland S; Hagness M; Line PD; Guren TK; Tveit KM; Foss A
Ann Surg Oncol; 2015 Jul; 22(7):2195-200. PubMed ID: 25297902
[TBL] [Abstract][Full Text] [Related]
53. Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy - a randomized phase II study -- SULTAN UCGI 30/PRODIGE 53 (NCT03164655)- study protocol.
Boilève A; Maillard A; Wagner M; Dromain C; Laurent C; Dupont Bierre E; Le Sourd S; Audemar F; Ulusakarya A; Guerin-Meyer V; Smisth D; Pezzella V; De Baere T; Goere D; Gelli M; Taieb J; Boige V
BMC Cancer; 2020 Jan; 20(1):74. PubMed ID: 32000724
[TBL] [Abstract][Full Text] [Related]
54. Efficacy of perioperative chemotherapy in patients with colorectal cancer undergoing hepatectomy for resectable synchronous liver metastasis.
Nakanishi M; Kuriu Y; Murayama Y; Konishi H; Komatsu S; Shiozaki A; Ikoma H; Kubota T; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Otsuji E
Hepatogastroenterology; 2014 Sep; 61(134):1582-7. PubMed ID: 25436346
[TBL] [Abstract][Full Text] [Related]
55. Nomogram for prediction of prognosis in patients with initially unresectable colorectal liver metastases.
Imai K; Allard MA; Castro Benitez C; Vibert E; Sa Cunha A; Cherqui D; Castaing D; Bismuth H; Baba H; Adam R
Br J Surg; 2016 Apr; 103(5):590-9. PubMed ID: 26780341
[TBL] [Abstract][Full Text] [Related]
56. Randomized trial of simplified LV5FU2 versus FOLFOX7 followed by FOLFIRI (MIROX) in patients with initially resectable metastatic colorectal cancer: a GERCOR study.
Hebbar M; Chibaudel B; André T; Louvet C; Smith D; Mineur L; Bennamoun M; Mabro M; Brusquant D; Bonnetain F; Pruvot FR; de Gramont A
J Chemother; 2013 Apr; 25(2):104-11. PubMed ID: 23684358
[TBL] [Abstract][Full Text] [Related]
57. Perioperative chemotherapy for resectable colorectal liver metastases: where now?
Jones RP; Malik HZ; Fenwick SW; Poston GJ
Eur J Surg Oncol; 2013 Aug; 39(8):807-11. PubMed ID: 23726258
[TBL] [Abstract][Full Text] [Related]
58. Long-Term Outcomes of Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastases.
Maeda Y; Shinohara T; Nagatsu A; Futakawa N; Hamada T
Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S242-8. PubMed ID: 25749931
[TBL] [Abstract][Full Text] [Related]
59. Secondary Metastases Resection After Bevacizumab Plus Irinotecan-Based Chemotherapy in First-Line Therapy of Metastatic Colorectal Cancer in a Real-Life Setting: Results of the ETNA Cohort.
Rouyer M; Smith D; Laurent C; Becouarn Y; Guimbaud R; Michel P; Tubiana-Mathieu N; Balestra A; Jové J; Robinson P; Noize P; Moore N; Ravaud A; Fourrier-Réglat A;
Target Oncol; 2016 Feb; 11(1):83-92. PubMed ID: 26298481
[TBL] [Abstract][Full Text] [Related]
60. Liver resection for primarily unresectable colorectal metastases downsized by chemotherapy.
Nuzzo G; Giuliante F; Ardito F; Vellone M; Pozzo C; Cassano A; Giovannini I; Barone C
J Gastrointest Surg; 2007 Mar; 11(3):318-24. PubMed ID: 17458605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
